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http://www.lipidworld.com/content/11/1/129RESEARCH Open AccessEffect of flaxseed supplementation and exercise
training on lipid profile, oxidative stress and
inflammation in rats with myocardial ischemia
Howaida A Nounou1,2*†, Maha M Deif3† and Manal A Shalaby2,4†Abstract
Background: Flaxseed has recently gained attention in the area of cardiovascular disease primarily because of its
rich contents of α-linolenic acid (ALA), lignans, and fiber. Although the benefits of exercise on any single risk factor
are unquestionable, the effect of exercise on overall cardiovascular risk, when combined with other lifestyle
modifications such as proper nutrition, can be dramatic.
This study was carried out to evaluate the protective role of flaxseed and exercise on cardiac markers, lipids profile
and inflammatory markers in isoproterenol (ISO)-induced myocardial ischemia in rats.
Methods: The research was conducted on 40 male albino rats, divided into 4 groups (n=10): group I served as
control, group II has acute myocardial ischemia induced by isoproterenol, groups III and IV have acute myocardial
ischemia induced by isoproterenol pretreated with flaxseed supplementation orally for 6 weeks, additionally group
IV practiced muscular exercise through swimming.
Results: Alterations of lipid profile, cardiac and inflammatory markers (Il-1β, PTX 3 and TNF- α) were observed in
myocardial ischemia group. Flaxseed supplementation combined with exercise training showed significant increase
of HDL and PON 1, on the other hand cardiac troponin, Il- 1β and TNF- α levels significantly decreased as
compared to myocardial ischemic group. Receiver Operating Characteristics (ROC) analysis of cTnI, PTX 3, Il-1β and
TNF- α revealed a satisfactory level of sensitivity and specificity.
Conclusion: Regular exercise enhances the improvement in plasma lipoprotein levels and cardiovascular protection
that results from flaxseed supplementation by mitigating the pathophysiology of atherosclerosis. Elevation of HDL,
the antioxidant PON 1 and the cardioprotective marker PTX 3 emphasizes the protective effects of flaxseed and
muscular exercise mutually against the harmful effects of acute myocardial ischemia.
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Coronary heart disease (CHD) is the single largest cause
of death in the developed countries and is one of the
leading causes of disease burden in developing countries
as well. In 2001, there were 7.3 million deaths and 58
million disability adjusted life years (DALYs) lost due to
CHD worldwide [1,2]. Reduction of heart oxygen supply* Correspondence: hnounou@ksu.edu.sa
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reproduction in any medium, provided the ordue to coronary obstruction leads to diminution of oxy-
gen supply to the mitochondria to support oxidative
phosphorylation and eventually ischemia [3]. Dietary
interventions, have recently received attention as effect-
ive strategies to prevent, mitigate, or reduce risk factors
of some diseases [4]. Considerable cardiovascular disease
researches focus on the cardioprotective effects of fish
oils and of individual n-3 PUFA [5,6]. Experimental evi-
dence suggests that regular consumption of (n-3) PUFA
is particularly effective in protecting against the dam-
aging effects of myocardial ischemia [7]. PUFA such as
linoleic acid and alpha-linolenic acid (ALA) cannot be
synthesized in the human body; therefore they must bel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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acids. Common sources of n-3 PUFA include fish oils
(eicosapentaenoic acid and docosahexaenoic acid) and
some plant oils such as canola and flaxseed oils (ALA).
Flaxseed is a rich source of PUFAS and contains an aver-
age of 41% oil. Some varieties contain 45–60% n- 3 fatty
acid [ALA; 18:3 (n-3)], which has been reported to in-
crease the cellular concentrations of eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA) in both
platelets and blood vessels [8]. In a case–control study
of 96 middle-aged men with incident stroke, Simon
et al. [9] found that a significant 0.06% increase in
phospholipid ALA content was associated with a 28%
decrease in the risk of stroke [10].
The effects of flaxseed supplementation on plasma lipids
have remained controversial. Some reports recorded that
flaxseed (12.5 g/day) prevented the rise in plasma trigly-
ceride levels over a 16-week feeding period in a hypercho-
lesterolemic rabbit model but had no effect on
triglycerides levels in low density lipoprotein receptor
(LDLr)−/− mice supplemented with 0.04 g/day of flaxseed
during 24 weeks. Others reported that dietary flaxseed
had no effect on cholesterol levels in rabbits, but even low
doses (0.04– 0.2 g/day) of dietary flaxseed significantly re-
duce plasma cholesterol levels in the LDLr−/− mice
[11,12].
Cardiac troponin (cTnI) has been established as one of
the most useful biomarkers for risk assessment and
management of suspected acute coronary syndromeTable 1 Levels of the cholesterol, triglyceride, LDL and HDL in
Lipid profile Groups
Triglycerides (mg/dl) (1) Control
(2) Cardiac ischemia
(3) Flaxseed supplemented
(4) Flaxseed with exercise
Cholesterol (mg/dl) (1) Control
(2) Cardiac ischemia
(3) Flaxseed supplemented
(4) Flaxseed with exercise
HDL (mg/dl) (1) Control
(2) Cardiac ischemia
(3) Flaxseed supplemented
(4) Flaxseed with exercise
LDL (mg/dl) (1) Control
(2) Cardiac ischemia
(3) Flaxseed supplemented
(4) Flaxseed with exercise
a: Significant difference between control and myocardial ischemia. b: Significant dif
difference between control and flaxseed with exercise group. d: Significant differen
Significant difference between groups 3,4.
*: P<0.05; **: P<0.001; ***: P<0.0001.patients. Previous studies reported that elevated cTnI
levels are highly specific for cardiac injuries [13-15].
Exercise training confers sustainable protection against
myocardial infarction in animal models and has been
associated with improved survival following a heart at-
tack in humans. It is still not clear the mechanism by
which exercise training protects the heart, but some
studies have suggested that it alters a number of classical
signaling molecules [1]. To gain insight about the car-
diovascular effects of flaxseed and to understand how
this substance works in our bodies, our experimental
studies have examined the prophylactic role of flaxseed
supplementation alone and in combination with exercise
in isoproterenol-induced myocardial ischemia in rats.
Results and discussion
Many studies have focused on improving lipid profiles (as
one of the most important risk factors of chronic diseases)
by planning a better diet or introducing herbal treatments.
Lipid profile improving effect of flaxseed has long been
studied and many literatures have related its effect to high
fiber, ALA and lignans content of flaxseed [16].
The comparison of blood lipid profiles of control and
studied groups after treatment period and ischemia
revealed that plasma triglyceride levels in the myocardial
ischemia group II was 34.2±3.0 mg/dl with increase up
to 263.1% relative to control (Table 1 and Figure 1). Ele-
vated triglyceride levels in group II the myocardial ische-
mia group could be due to decreased activity ofplasma of control and experimental groups of rats
Median Interquartile Range Mean
12.8 12.2-13.8 13.0
34.5 32.8-36.8 34.2 a***




28.0 26.8-30.8 28.8 d***




34.3 32.8-36.2 34.3c***, E***, F***
43.3 33.7-46.0 41.5
34.3 31.5-36.4 33.9 a*
27.4 24.1-28.9 26.3b***, d***
24.4 23.0-26.3 24.5c***, E***,
ference between control and flaxseed supplemented rats. c: Significant
ce between groups 2,3. E: Significant difference between groups 2,4 F:
Figure 1 Triglycerides, cholesterol, HDL and LDL levels measured in plasma of the different studied rat groups. Triglycerides and
cholesterol levels increased after ischemia in rat’s plasma. Treatment with flaxseed separately and in combination with exercise attenuated the
increase in triglycerides and cholesterol levels. HDL slightly decreased after ischemia in plasma of untreated rats and flaxseed treated rats.
Combined treatment with flaxseed and exercise markedly increased HDL level in rat’s plasma. LDL slightly decreased after ischemia in plasma.
Treatment with flaxseed separately and in combination with exercise markedly decreased LDL levels in rat’s plasma. Data from plasma of ten rats
in each group are shown as mean ± S.D.
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Alterations in the lipid profiles of isoproterenol-treated
rats, attributed to enhanced lipid biosynthesis by cardiac
cyclic adenine monophosphate (cAMP) may be respon-
sible for the triglyceride elevation in group II [18].
Flaxseed supplementation in group III has increased
plasma triglycerides to 14.6±1.2 mg/dl with increase up
to 112.3% relative to control (P <0.05). Flaxseed supple-
mentation combined with exercise training has increased
triglycerides to 15.2±2.1 mg/dl with increase up to
116.9% as compared to the control group (P <0.001)
(Table 1 and Figure 1). Previous studies reported that
elevated triglyceride levels may depend on nutritional
basis which could explain the elevated level of triglycer-
ides in groups III and IV which received flaxseed supple-
mentation [19].Table 2 Levels of cardiac troponin and paraoxonase 1 in plas
Cardiac markers Groups M
Cardiac troponin (ng/ml) (1) Control 0
(2) Cardiac ischemia 0
(3) Flaxseed supplemented 0
(4) Flaxseed with exercise 0
Paraoxonase 1 (ng/ml) (1) Control 9
(2) Cardiac ischemia 8
(3) Flaxseed supplemented 7
(4) Flaxseed with exercise 9
a: Significant difference between control and myocardial ischemia. b: Significant dif
difference between control and flaxseed with exercise group. d: Significant differen
Significant difference between groups 3,4.
*: P<0.05; **: P<0.001; ***: P<0.0001.A remarkable elevation of cholesterol level to 69.6
±9.2 mg/dl with increase up to 249.5% relative to control
(P <0.0001) was determined and attributed to myocar-
dial ischemia in group II. Flaxseed supplementation in
group III dropped cholesterol level to nearly the control
level 28.8±2.8 mg/dl with mild increase of 103% com-
pared to control. Cholesterol level decreased signifi-
cantly due to exercise training combined with flaxseed
in group IV to 26.4±1.0 mg/dl compared to myocardial
ischemia group (P <0.0001) with decrease down to
94.6% relative to control (Table 1 and Figure 1).
The myocardial ischemia group II has LDL level of 33.9
±2.8 mg/dl, which is significantly higher than group III
(flaxseed supplemented group and group) IV (flaxseed
supplemented group combined with exercise training)
(P <0.0001). Flaxseed supplementation in group III decreasedma of control and experimental groups of rats
edian (IQR) Interquartile Range Mean
.2 0.2-0.3 0.2
.8 0.7-1.0 0.97 a***
.2 0.2-0.2 0.2 d***
.3 0.3-0.4 0.3c**, E***, F***
2.6 89.6-94.7 92.3
3.4 82.6-85.4 83.6 a***
7.5 73.5-79.0 75.9 b***, d****
9.0 97.0-101.3 99.0 c***, E***, F***
ference between control and flaxseed supplemented rats. c: Significant
ce between groups 2,3. E: Significant difference between groups 2,4 F:
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tive to control, while exercise training combined with flax-
seed supplementation decreased LDL to 24.5±1.8mg/dl
with decrease down to 59% in group IV as compared to
the control (Table 1 and Figure 1). The reported decrease
of total cholesterol and LDL in group III and group IV
could be due to the protective effects of lignan complex
isolated from flaxseed in reducing the extent of hypercho-
lesterolemic atherosclerosis [20].
On the other hand, there was a significant increase of
high density lipoprotein (HDL) to 34.3±1.9 mg/dl in
group IV which was on flaxseed supplementation and
exercise training as compared with the other groups
(P <0.0001), with increase up to 129.4% increase as com-
pared to the control (Table 1 and Figure 1). Flaxseed
supplementation in group III was ineffective towards
producing alterations in plasma HDL which is 24.2±1.9
mg/dl with decrease down to 91.3% compared to control
(Table 1 and Figure 1). Most previous studies reported
no changes in HDL levels in response to dietary flaxseed
[11]. The significant increase in HDL due to flaxseed
supplementation and exercise may be explained by
stimulation of lipid oxidation during activity and in post
exercise recovery. Alterations in the transport of blood
lipids, with a higher ratio of HDL to LDL increased lipo-
protein lipase activity, which increases the use of circu-
lating triglycerides as fuel and increases their clearance.
Activation of this enzyme also speeds up the conversion
of the very low density lipoproteins (VLDL) to HDL
[21,22].
While the marker of ischemic myocardial injury cTnI
has increased due to myocardial ischemia in group II toFigure 2 cTnI and PTX 3 levels measured in plasma of the different st
Treatment with flaxseed separately and in combination with exercise atten
in plasma. Treatment with flaxseed attenuated the increase in PTX 3 level.
in rat’s plasma. Data from plasma of ten rats in each group are shown as m0.97±0.4 ng/ml with increase up to 485% as compared
to the control, flaxseed supplementation in group III
ameliorated the level of cTnI to 0.2±0.02 ng/ml (P <
0.0001) almost 100% as the control. Flaxseed supple-
mentation combined with training in group IV increased
cTnI to 0.3±0.04 ng/ml with elevation up to 150% as
compared to control as shown in Table 2 and Figure 2.
The antiatherogenic potential benefits of flaxseed, that
has been received in both group III and IV, protected
against the loss of endothelial-dependent vascular relax-
ation in cholesterol fed animals [23]. The protective ef-
fect of flaxseed has been deteriorated in group IV by the
viable release of myocytes cTnI through stretch- related
mechanism mediated by integrins [24].
While Paraoxonase (PON 1), HDL associated enzyme,
is capable of inhibiting LDL oxidation, susceptibility to
coronary artery disease has shown to be associated with
polymorphisms of PON gene (PON 1) in different popu-
lation [14]. The antioxidant activity of HDL is believed
to reside in its associated enzymes, particularly PON 1.
To evaluate this correlation we measured PON 1 in all
the studied groups. Data in Table 2 and Figure 3 showed
a significant decrease in PON 1 in myocardial ischemia
level to 83.6±2.0 ng/ml with decrease to 90.6% relative
to control (P < 0.0001). Plasma PON 1 levels signifi-
cantly decreased to 75.9±4.1 ng/ml with a decrease to
82.2% relative to the control due to flaxseed supplemen-
tations in group III (P < 0.0001). The significant increase
of PON 1 in group IV to 99.0±2.2 ng/ml compared with
other groups (P < 0.0001) with increase to 107.3% com-
pared to control may be due to the training exercise
associated with flaxseed supplementation in this group.udied rat groups. cTnI markedly increased after ischemia in plasma.
uated the increase in cTnI levels. PTX 3 levels increased after ischemia
Combined treatment with flaxseed and exercise increased PTX 3 level
ean ± S.D.
Figure 3 PON 1 levels measured in plasma of the different studied rat groups. PON 1 decreased after ischemia in plasma of untreated
group and flaxseed treated rats. Treatment with flaxseed in combination with exercise increased PON 1 level in rat’s plasma. Data from plasma of
ten rats in each group are shown as mean ± S.D.
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oxidative capacity and the moderate intensity exercise
training [25,26].
Interleukin- 1β (IL-1β) levels, showed a significant in-
crease in group II (the myocardial ischemia group) up to
127.8±4.0 pg/ml with increase up to 213% relative to the
control group control group (P < 0.0001) (Table 3 and
Figure 4). This could be due to the proinflammatory role
of IL-1β in ischemic diseases [27]. IL-1β stimulates in-
flammatory cells like leukocytes, and induces systemic
inflammatory reactions like the expression of acute-
phase proteins in the liver. Leukocyte IL-1β expressionTable 3 Levels of the inflammatory markers IL-1β, PTX 3 and
rats
Inflammatory markers Groups
Interleukin 1-beta (pg/ml) (4) control
(2) Cardiac ischemia
(3) Flaxseed supplemented
(4) Flaxseed with exercise
Pentraxin 3 (ng/ml) (1) Control
(2) Cardiac ischemia
(3) Flaxseed supplemented
(4) Flaxseed with exercise
TNF-alpha (pg/ml) (1) Control
(2) Cardiac ischemia
(3) Flaxseed supplemented
(4) Flaxseed with exercise
a: Significant difference between control and myocardial ischemia. b: Significant dif
difference between control and flaxseed with exercise group. d: Significant differen
Significant difference between groups 3,4.
*: P<0.05; **: P<0.001; ***: P<0.0001.is induced in the ischemic and reperfused heart [28].
Previous studies reported that flaxseed exerts anti-
inflammatory actions and antioxidant potential [29] and
that the important antiatherogenic role of ALA may in-
volve a potent anti-inflammatory role [10]. This could
explain the significant decrease in plasma IL-1β levels in
group III which received flaxseed supplementation to
35.1±4.8 pg/ml as compared with the myocardial ische-
mia group II (P <0.0001) with decrease down to 58.5%
relative to the control (Table 3 and Figure 4).
IL-1β has significantly increased in group IV which
was on combined flaxseed supplementation and exerciseTNF-α in plasma of control and experimental groups of
Median Interquartile Range Mean
59.5 57.0-60.3 60.0
128.0 125.5-130.8 127.8 a***
34.7 33.0-40.0 35.1 b***, d***




0.38 0.24-0.41 0.35 c**, F***
26.6 20.7-30.2 25.9
30.7 29.3-31.0 30.3a*
22.4 21.2-24.9 23.5 d***
25.0 23.7-26.5 24.9 E***
ference between control and flaxseed supplemented rats. c: Significant
ce between groups 2,3. E: Significant difference between groups 2,4 F:
Figure 4 IL-1β and TNF-α levels measured in plasma of the different studied rat groups. IL-1β increased markedly after ischemia in plasma.
Treatment with flaxseed separately and in combination with exercise attenuated the increase in IL-1β levels. TNF-α levels increased after ischemia
in plasma. Treatment with flaxseed separately and in combination with exercise attenuated the increase in TNF-α level. Data from plasma of ten
rats in each group are shown as mean ± S.D.
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mentations (P <0.0001). The upturn in IL-1β in group
IV reached 58.1±14.4 pg/ml with decrease down to
96.8% compared to the control group (Table 3 and Fig-
ure 4). Moldoveanu et al. 2000; reported that exercise
induces an elevation in circulating inflammatory mar-
kers, which may be due to metabolic events and immune
function including increased glucose use, lactate accu-
mulation and leukocyte counts [30]. The type of physical
activity, as well as the intensity and duration of the exer-
cise has been reported to affect the cytokine profile [31].
The mechanism for inhibition of the tumor necrosis fac-
tor (TNF-α) and IL-1β synthesis by dietary n-3 fatty
acids is unknown, but may be explained by the fact that
n-6 eicosanoid synthesis is inhibited by n-3 fats, and n-6
eicosanoids can affect cytokine synthesis. Leukotriene B4
is a possible mediator because its synthesis can be inhib-
ited by n-3 fatty acids and it is reported to be a simula-
tor of TNF-α and IL-1β production [32].
TNF-α is a prominent element in the cytokine hypoth-
esis of heart disease and has been the focus of research
in myocardial ischemia [2]. Table 3 and Figure 4 showedTable 4 Receiver-operating (ROC) characteristic analysis of th
Parameter Area under the curve Bes
Cardiac troponin 1.0 0.51
Paraoxonase 1 0.0 –
Interleukin-1β 1.0 96.5
Pentraxin 3 1.0 0.22
TNF-α 0.83 28.5
Analysis of cardiac troponin, paraoxonase 1, interleukin -1β, pentraxin 3 and TNF- α
parameters except for paraoxonase 1 have area under the curve (AUC) near 1 and aa significant increase of plasma TNF-α in the myocardial
ischemia group II to 30.3±0.9 pg/ml with increase up to
117% as compared to the control group P < 0.05. These
results are in agreement with previous work stating that
over-production of TNF-α contributes to cardiac dys-
function through increase of TNF-α gene expression and
peptide synthesis in the myocardium that are associated
with NF-kappaB activation [33]. There was diminution
in plasma TNF- α to 23.5±3.2 pg/ml with decrease down
to 90.7% change in group III as compared to the control
group, this is in accordance with previous data demon-
strating that flaxseed consumption inhibits TNF-α syn-
thesis and reduces cytokine production by peripheral
mononuclear cells [34]. Group IV which received flax-
seed supplementation and exercise training showed
plasma levels of TNF-α 24.9±2.0 pg/ml with decrease
down to 96.1% as compared to control group (Table 3
and Figure 4).
There was a significant decrease in TNF-α levels in
groups III and IV as compared to the myocardial ische-
mia group (P < 0.0001) (Table 3 and Figure 4). Three
studies reported anti-inflammatory effects of flaxseed ine predictive value of cardiac and inflammatory markers






in myocardial ischemia rats and their controls (n=20). All the tested
ppropriate levels of specificity and sensitivity.
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including reductions in inflammatory markers, such as
TNF- α, IL-1β, thromboxane B5, prostaglandin E5, sol-
uble vascular cell adhesion molecule-1 (sVCAM-1), sol-
uble E-selectin, and serum C- reactive protein (CRP)
levels [35-38]. However, the majority of clinical dietary
intervention trials investigating the effects flaxseed on
markers of inflammation have reported no effect on
serum levels of IL-6, TNF-α, soluble intercellular cell ad-
hesion molecule-1, sVCAM-1, monocyte chemoattract-
ant protein-1, CRP, or serum amyloid A (SAA) protein
[39,40].
Recent research reported that moderate endurance ac-
tivity influenced circulating cytokine levels specially the
TNF- α levels which could be due to production of IL-6
produced by exercising muscle as an anti-inflammatory
effect [41].
Pentraxin 3 (PTX 3) has been proposed as candidate
marker for acute and chronic heart diseases [12]. PTX3
synthesis is stimulated in endothelial cells, macrophages,
myeloid cells, and dendritic cells by cytokines and endo-
toxins such as bacterial products, interleukin-1, and
TNF-α [10-13]. Our results showed a significant increase
in PTX 3 levels in myocardial ischemia group II to 0.3
±0.05 ng/ml with increase up to 200% relative to control
( P < 0.0001) (Table 3 and Figure 2). This has been in
correlation with the elevated levels of tissue mRNA ex-
pression and circulating PTX 3 reported in a model of
acute myocardial infarction which was explained by the
role played by interleukin-1R-MyD88 in inducing PTX 3
transcript after ischemia. [12,41,42]. A significant in-
crease of plasma PTX 3 was observed in group IV that
were receiving flaxseed supplementation and on exercise
(0.35±0.11ng/ml) as compared to group I the control
group (0.15±0.04 ng/ml) and to group III that was on
flaxseed supplementation only (0.18±0.12 ng/ml) (P<
0.001, P< 0.001 respectively). The increment in PTX 3
levels due to flaxseed supplementation and exercise was
up to 233.3% compared to the control group (Table 3
and Figure 2).
The elevated levels of PTX 3 in group IV is in concur-
rence with the increased levels of HDL in the same
group as compared with sedentary controls. Plasma PTX
3 levels increases with cardiovascular disease, suggesting
that plasma PTX 3 levels may increase in order to confer
protection against cardiac tissue damage [43]. The im-
portance of pentraxin in protection against cardiovascu-
lar diseases has been established in the PTX 3-knockout
mice which acquired exacerbated heart damage and
increased inflammatory response [43]. Data obtained in
animal models of CVD suggest that, pentraxin might
play a marked protective response to severe cardiac in-
jury more than a role in the pathogenesis of damage
[44]. These findings would suggest that PTX 3 could beeither a bystander resulting from the action of proin-
flammatory cytokines in damaged tissues or a molecule
directly involved in the extent and outcome of the in-
flammatory response.
Our results showed alterations in the lipid profiles of
isoproterenol-treated rats (group II); with increase of
total cholesterol and triglycerides, the marker of ische-
mic myocardial injury, cTnI also increased in the same
group, all the inflammatory biomarkers IL-1β, PTX 3
and TNF- α level increased with myocardial ischemia.
Flaxseed supplementation in group III has returned
the levels of total cholesterol and triglycerides to almost
the same levels as the control while LDL decreased far
below the control. The marker of ischemic myocardial
injury cTnI also returned to same level as control. The
inflammatory biomarkers, PTX 3 and TNF-α decreased
to almost same level as the control, while IL- 1β
decreased to a level much below the control level.
Flaxseed supplementation combined with muscular
exercise had the same improving effect as flaxseed ex-
cept for the significant increase of HDL which was con-
sidered as highly beneficial; the cardiac marker
paraoxonase also increased which would be expected
with exercise. We have also identified a slight rise of the
inflammatory biomarker TNF- α and a significant in-
crease of IL-1β as compared to flaxseed supplementation
only. There was also a significant increase of the cardio-
protective marker pentraxin in this group.
Receiver Operating Characteristics (ROC) analysis pre-
sented in Table 4, supports the previous discussion and
suggestions which are based on the obtained data. cTnI,
PTX 3, IL-1 β and TNF- α values recorded area under
the curve (AUC) near 1 and satisfactory levels of specifi-
city and sensitivity and hence they could be used as bio-
chemical markers for detection of protective effects of
flaxseed and muscular exercise.
Conclusion
This study highlights that combination of flaxseed and
exercise is one of the promising cytoprotective elements
for improving defense mechanisms in the physiological
systems against oxidative stress and inflammation caused
by myocardial ischemia.
Methods
The study was conducted on 40 adult male albino rats,
of body weight 150–200 g obtained from Animal Care
Centre, Alexandria University, Egypt. The animals were
kept in a 12-hour light/dark cycle, at a temperature of
22°C ± 2°C with relative humidity 50% ± 20%, and venti-
lated with filtered non-recycled air. They were fed on
standard chow pellets (Gebze Food Factory, Kocaeli,
Turkey) and tap water ad libitum for the entire test
period. The experimental procedures were carried out
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for Animal Care and approved by the Local Ethics Com-
mittee, Alexandria University.
Chemicals and reagents
Flaxseed was purchased from General Nutrition Corpor-
ation; Pittsburgh, PA 15222 USA. The components of
flaxseed were as following typical fatty acid profile per
serving; alpha-linolenic acid (ALA) (Omega-3); 7700 mg,
linoleic acid (LA)(Omega-6); 2170 mg, oleic acid (OA)
(Omega-9); 2240 mg. Amount per serving; calories;
130.00, calories from fat; 130.00, total fat; 14.00 g,
saturated fat; 1.50 g, trans fat; 0.00 g, polyunsaturated
fat; 10.00 g, monounsaturated fat; 2.50 g; cholesterol;
0.00 mg, sodium 0.00 mg, total carbohydrate 0.00 g, pro-
tein 0.00 g. Isoproterenol was purchased from Yangzhou
O & L Chemical Industry Co., Ltd. All other chemicals
used in this study were of high analytical grade. Kits for
cholesterol, triglyceride and HDL-cholesterol were pur-
chased from Randox Laboratories Ltd. (CRUMLIN, CO.
Antrim, UK). Kits for high sensitivity cTnI was pur-
chased from Life Diagnostics, Inc., TNF-α and IL-1β kits
were purchased Quantikine Immunoassay kits (R&D
Systems, Inc, USA), PTX 3 kit was from CUSABIO BIO-
TECH Co., Ltd. and PON-1 kit was purchased from Life
Science Co.
Study design
Rats were divided into 4 groups (n=10):
Group I: served as a control group, treated orally with
saline for 6 weeks and then injected subcutaneously
with saline for 2 consecutive days.
Group II: was treated with isoproterenol
subcutaneously (85mg/kg) for 2 consecutive days [45]
for induction of myocardial ischemia.
Group III: received flaxseed oil orally by gavage tube in
a dose of 0.4 g/day for six weeks then myocardial
ischemia was induced by isoproterenol as described in
group II [11,12].
Group IV: was trained with exercise preconditioning in
the form of mere swimming. The swimming exercise
was performed in a 120 cm deep x 80 cm wide
cylindrical tank, with water temperature of 31 ± 1°C.
After one week of acclimatization, the swimming
protocol was started. Swimming was performed for 6
weeks, 5 days per week and one hour per day [46], in
addition, this group (IV) was treated with flaxseed
supplementation as group III, and then myocardial
ischemia was induced after two days of relaxation from
exercise by isoproterenol in same way as group II.
At the end of the experimental period,12 hours fast-
ing after the second dose of isoproterenol injection, ratswere sacrificed by decapitation under ether anaesthesia
and blood was collected in EDTA containing tubes.
After the samples were collected, all sample tubes were
centrifuged at 1500 rpm for 10 min at 4 °C to separate
plasma. Plasma lipids were measured. The remaining
part of the plasma was immediately aliquoted into
eppendorf tubes placed on ice and immediately stored
at −80 °C until ELISA measurements of high sensitivity
cTnI, TNF-α, IL-1β, pentraxin-3 and paraoxonase-1
were performed.
Assessment of lipid profile
Total cholesterol was measured by enzymatic colori-
metric cholesterol oxidase and peroxidase method
[47], HDL by phosphotungstic acid, magnesium ions
precipitate LDL and VLDL, after centrifugation HDL-
cholesterol was determined by cholesterol oxidase and
peroxidase method [47]. LDL-cholesterol was calcu-
lated using Friedewald formula as following, LDL
(mg/dl) = Total cholesterol –HDL-cholesterol- TAG/5
[48].
Assessment of cardiac troponin, inflammatory markers and
anti-inflammatory marker
Assay of cTnI, TNF-α, IL-1β, PTX 3 and PON 1 were
investigated in plasma samples and their plasma levels
were determined using ELISA technique according to
the manufacturer's instructions.
Statistical analysis
The raw data were coded and transformed into coding
sheets. The results were checked. Then, the data were
entered into SPSS system files (SPSS package version 18)
using personal computer. Output drafts were checked
against the revised coded data for typing and spelling
mistakes. Finally, analysis and interpretation of data were
conducted.
The following statistical measures were used:
 Descriptive statistics including frequency, mean, and
standard deviation were used to describe different
characteristics.
 Kolmogorov – Smirnov test was used to examine
the normality of data distribution.
 Univariate analyses including: Mann Whitney test,
Kruskal Wallis test, and Tamhane post Hoc test
were used to test the significance of results of
quantitative variables.
 Diagnostic performance of CT, paraoxonase,
interleukin 1-beta, pentraxin, TNF-α in diagnosing
myocardial ischemia rats were assessed by sensitivity
and specificity using ROC analysis.
 The significance of the results was at the 5% level of
significance.
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